Company Filing History:
1 out of 167 
1 out of 822 
Years Active: 2020
Title: Jeroen Van Bergeijk: Innovator in Pharmaceutical Chemistry
Introduction
Jeroen Van Bergeijk is a notable inventor based in Ludwigshafen, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate S1P receptors.
Latest Patents
Jeroen holds a patent for "Fused heterocyclic compounds as S1P modulators." This invention relates to heterocyclic compounds that act as S1P modulators, along with pharmaceutical compositions that include these compounds. The applications of this invention are aimed at the treatment, alleviation, or prevention of diseases or disorders mediated by S1P receptors.
Career Highlights
Throughout his career, Jeroen has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His work has focused on innovative solutions that address critical health challenges.
Collaborations
Jeroen has collaborated with esteemed colleagues such as Udo Lange and Michael Ochse, contributing to advancements in pharmaceutical research and development.
Conclusion
Jeroen Van Bergeijk's work exemplifies the impact of innovation in the pharmaceutical sector, particularly through his patented inventions that hold promise for treating various medical conditions.